Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

18.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.4K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

734
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
734
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

655
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
655
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.0K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.0K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

177
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
177

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same authorSame journal

[Prognostic significance of dynamic evaluation of C-peptide level in prediction type 1 diabetes mellitus in children].

Problemy endokrinologii·2026
Same authorSame journal

[Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children].

Problemy endokrinologii·2026
Same author

[Clinical, hormonal and molecular genetic characteristics of 18 cases of disorders of sex development (DSD) 46,XY associated with variants in the <i>SRD5A2</i> gene].

Problemy endokrinologii·2026
Same author

[Differentiated thyroid carcinoma in children and adolescents].

Problemy endokrinologii·2026
Same author

[Non-classic lipoid adrenal hyperplasia: clinical cases report].

Problemy endokrinologii·2026
Same author

[Unsolved dental problems in children with congenital hyperinsulin].

Stomatologiia·2025

関連する実験動画

Updated: Feb 6, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.4K

Culler-Jones症候群の多型

E N Raykina1, A A Kolodkina1, A V Bolmasova1

  • 1Endocrinology Research Centre.

Problemy endokrinologii
|February 5, 2026
PubMed
まとめ

GLI2遺伝子変異によって引き起こされるCuller-Jones症候群は、著しい臨床的多様性と不完全浸透率を示します。この研究は、影響を受けた子供たちにおいて明確な遺伝子型-表現型相関がないことを強調しています。

キーワード:
Culler-Jones症候群GLI2遺伝子遺伝子型-表現型相関多型不完全浸透率

さらに関連する動画

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K
The Visual Colorimetric Detection of Multi-nucleotide Polymorphisms on a Pneumatic Droplet Manipulation Platform
10:01

The Visual Colorimetric Detection of Multi-nucleotide Polymorphisms on a Pneumatic Droplet Manipulation Platform

Published on: September 27, 2016

8.0K

関連する実験動画

Last Updated: Feb 6, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.4K
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K
The Visual Colorimetric Detection of Multi-nucleotide Polymorphisms on a Pneumatic Droplet Manipulation Platform
10:01

The Visual Colorimetric Detection of Multi-nucleotide Polymorphisms on a Pneumatic Droplet Manipulation Platform

Published on: September 27, 2016

8.0K

科学分野:

  • 遺伝学
  • 小児科学
  • 内分泌学

背景:

  • Culler-Jones症候群は、GLI2遺伝子に関連するまれな常染色体優性疾患です。
  • その臨床像は、甲状腺機能低下症、臓器奇形、顔面奇形、多指症など、非常に多様です。
  • 不完全浸透率と可変性表現は、家族内でも特徴的です。

研究 の 目的:

  • Culler-Jones症候群の臨床的および分子遺伝学的特徴を調査すること。
  • Culler-Jones症候群と診断された患者における多型の分析。

主な方法:

  • 遺伝的に確認されたCuller-Jones症候群の子供たちを対象とした単一施設、非介入研究。
  • 包括的な臨床検査、検査室検査、および機器診断が実施されました。
  • 分子遺伝学的分析には次世代シーケンシング（NGS）が利用されました。

主要な成果:

  • 対象となったGLI2遺伝子変異を有する18人の子供（女性7人、男性11人）を研究しました。
  • すべての参加者は成長ホルモン欠損症を示しました。
  • 13人は中枢性甲状腺機能低下症、10人は二次性副腎機能低下症でした。
  • 上顎顔面異常や臓器奇形を含む、下垂体外の症状が患者の半数に観察されました。

結論:

  • Culler-Jones症候群は、著しい臨床的多型を示します。
  • この状態に対して、明確な遺伝子型-表現型相関は特定されませんでした。